Conditions that can be affected by activating or inhibiting type 1 (CB1) or type 2 (CB2) cannabinoid receptors independently.
Credit
Xiaoting Li <em>et al./Cell</em>
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.